COEP
Coeptis Therapeutics Holdings, Inc.
Key Financials
Revenue
$1.4M
↑ Infinity%
Operating Income
$-13043498
↓ 29.7%
Net Income
$-11917015
↓ 9.6%
Total Liabilities
$2.1M
↓ 58.6%
Gross Profit
$1.2M
↑ Infinity%
Total Assets
$16.2M
↑ 81.3%
EPS (Diluted)
$-2.81
↑ 50.3%
Cash & Equivalents
$404345.00
↓ 55.4%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | COEP |
| Company Name | Coeptis Therapeutics Holdings, Inc. |
| CIK | 1759186 |
| SIC Code | 6199 |
| SIC Description | Finance Services |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 724-934-6467 |